18 
DNA molecules was an important element of regulation. It was the consensus 
of the Committee that registration should occur prior to the initiation 
of the project, but that approval before commencing the project should 
not be required. Further, the Committee recommends that the Secretary 
have the authority to exempt certain classes of projects from this 
requirement . 
(4) Licensure of Facilities : 
It was the consensus of the Committee that the licensure provision 
should apply only to facilities, and that the facility would, under the 
terms of its license, accept responsibility for the particular activities 
and individuals at the facility. The Committee concluded that licensure 
of the facility and registration of projects would meet the needs for 
safety monitoring without extension of licensure to the projects themselves. 
The Committee discussed the possibility of revoking a license for serious 
and willful violations of the regulations. There was concern expressed that 
revocation was a very punitive measure, but it was agreed that the Secretary 
may wish to consider it for serious violations of the standards. 
(5) Disclosure of Information : 
It was the scientific community that brought to public attention 
potential hazards of recombinant DNA research, and the NIH Guidelines, in 
that spirit, promote disclosure and dissemination of scientific and safety 
information. The Committee urges full disclosure to the appropriate 
regulatory body of all relevant safety and scientific information on the 
use or production of recombinant DNA molecules. However, the Committee 
[298] 
